Newsroom

Sorted by: Latest

-

Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be participating at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 10, 2026 in Snowbird, UT. About Adagio Medical Holdings, Inc. Adagio is a medical device company focused on developing...
-

Gibraltar Completes Acquisition of Omnimax International for $1.335 Billion

BUFFALO, N.Y.--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential, agtech, and infrastructure markets, today announced that it has closed its acquisition of OmniMax International ("OmniMax") from funds managed by Strategic Value Partners, LLC and its affiliates following receipt of all required regulatory approvals and satisfaction of customary closing conditions. The all-cash transaction was valued at $1....
-

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions

PALO ALTO, Calif. & ROCHESTER, Minn.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the largest study to date evaluating circulating tumor DNA (ctDNA) for MRD detection in patients with resected stage III colon cancer after surgery and before adjuvant chemotherapy. Results of the study, published in the Journal of Clinical Oncology...
-

VerifyMe, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement

LAKE MARY, Fla.--(BUSINESS WIRE)--VerifyMe, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement...
-

Genius Gourmet® Builds Momentum with SKIPPY®-Inspired Protein Snacks Across Grocery and Convenience

COEUR D’ALENE, Idaho--(BUSINESS WIRE)--Following the successful introduction of its three SKIPPY®-inspired protein snack items earlier this year, Genius Gourmet® is building momentum as the lineup gains traction across key grocery retailers and expands into the convenience channel. The SKIPPY®-inspired lineup includes: Genius Gourmet® SKIPPY® Crispy Protein Bar: a modern take on the classic crispy treat, made with SKIPPY® Natural Peanut Butter Spread and delivering 12 grams of protein (24% DV)...
-

Alliant Insurance Services Awarded Sourcewell Contract, Expands Public Entity Insurance Access Nationwide

IRVINE, Calif.--(BUSINESS WIRE)--Alliant was competitively awarded a cooperative purchasing contract by Sourcewell, a service cooperative for participating public entities....
-

Bank AI Uses Cases Examined in Latest Bankers as Buyers Research Highlight & Expert Panel Report™

ATLANTA--(BUSINESS WIRE)--William Mills Agency, the nation’s leading fintech public relations and marketing firm, has published a new issue of its Bankers as Buyers™ Research Highlight & Expert Panel report exploring what today’s most common artificial intelligence (AI) use cases reveal about the future direction of the banking industry. Download the free Bankers as Buyers Research Highlight & Expert Panel here. This research highlight examines findings from the ProSight Banking Outlook...
-

Mineros S.A. Announces Evaluation of Potential Corporate Re-domiciliation and Calls Special Meeting of Shareholders

MEDELLÍN, Colombia--(BUSINESS WIRE)--Mineros S.A. (TSX:MSA, OTCQX:MNSAF, BVC:MINEROS) (“Mineros” or the “Company) announces that its Board of Directors has initiated a formal evaluation of a potential corporate re-domiciliation or related reorganization involving the Company’s jurisdiction of incorporation. Strategic Review and Structural Considerations The Company is assessing the legal, fiscal, regulatory, and operational implications of a potential reorganization of its corporate structure....
-

Sierra Bancorp Reports Record Quarterly Earnings and 2025 Results

PORTERVILLE, Calif.--(BUSINESS WIRE)--Sierra Bancorp Reports Record Quarterly Earnings and 2025 Results...
-

Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that its New Drug Application (NDA) for zanzalintinib, in combination with atezolizumab (Tecentriq®), has been accepted for review in the U.S. for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, and, if RAS wild-type, an anti-epidermal growth factor receptor (EGFR) therapy. The Food and D...